 The study also found that the cost of the drugs ranged from $20,000 to $180,000 despite the lack of scientific evidence of benefit.In 2017, staff published a paper in the peer-reviewed policy journal Milbank Quarterly criticizing the FDA for its failure to safeguard electronic health records and other device software from hacking and other cybersecurity threats.They stated “ current regulations are necessary but not sufficient for ensuring patient safety by identifying and eliminating dangerous defects in software currently on the market”.